Dr. Daniel Wong

Dermatologist, Oakville, ON

Dermatologist, deRMA Skin Institute, Burlington, ON | Dermatologist, Medcan, Oakville, ON

Dr. Wong is a board-certified dermatologist and Fellow of the Royal College of Physicians of Canada. Dr. Wong completed a Bachelor of Medical Sciences in Honours Clinical Biochemistry at Western University. He then went on to obtain his Medical Doctorate from Western University in 2014. He completed his 5-year dermatology residency at the University of Toronto in 2019. Dr. Wong has a special interest in skin cancer, dermatological surgery, psoriasis, atopic dermatitis, and medical education.

1:05 PM - 1:55 PM

NOV 3 (Fri)

Seb D or Not to B? That is the Clinical Question


  1. Analyze and review the current understanding of the pathogenesis involved in seborrheic dermatitis
  2. Discuss the heterogenous clinical presentations of seborrheic dermatitis and other similar inflammatory/pruritic skin conditions
  3. Examine the benefits and challenges of current treatment options for seborrheic dermatitis and explore future treatment options

Summary Description: Join us on a Shakespearean exploration where the many facets of seborrheic dermatitis will be brought to the stage. In the opening act, our expert moderator/director, Dr. Sam (Hamlet) Hanna, will review our present understanding on the multifactorial pathogenesis of this common chronic inflammatory condition. In the following acts, our expert speakers, Dr. Melinda Gooderham, Dr. Daniel Wong, and Dr. Geeta Yadav, will discuss varying clinical points of perspective on the commonalities and differences between seborrheic dermatitis and other inflammatory/pruritic skin conditions with respect to the pathophysiology and clinical presentations. This open session will also examine the efficacy, safety, and tolerability of current topical treatments. The final act will explore new developments in topical treatment for seborrheic dermatitis. Those in attendance at the theatre will gain a better understanding of the treatment strategies and unmet needs in the management of patients with this common chronic inflammatory dermatosis.